None
SK
Eli Lilly (LLY) Targets Black-Market Sales of Unapproved Weight-Loss Drug in Legal Battle
['Trader Edge']
Blockonomi
Eli Lilly and Company, LLYThe legal actions name Aesthetic Envy Cosmetic Centers, Astra, Legendary Peptides, Striker Pharmacy, Texas Peptides, and Lone Star Peptide as defendants.
The corporation is additionally urging digital platforms, online marketplaces, financial transaction processors, banking institutions, and logistics companies to implement more rigorous measures against distributors of unauthorized retatrutide products.
Border Confiscations Escalate DramaticallyThe magnitude of unauthorized distribution continues expanding rapidly.
The dramatic increase in border seizures demonstrates the accelerating expansion of unauthorized GLP-1 medication distribution networks, fueled by substantial consumer appetite for weight management solutions.
Lilly’s enforcement initiative against unauthorized retatrutide distribution predates the current legal filings.